These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 703670)

  • 21. [Immunohematologic studies on the correlations between (+)-cyanidanol-3-(catergen) therapy and hemolytic anemia].
    Pausch V; Göbel J
    Wien Med Wochenschr; 1983 Nov; 133(21):559-65. PubMed ID: 6419470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of chronic hepatitis patients with catergen].
    Karkishchenko NN; Okorokov AN; Fedorov NE; Laktionova AA; Sidorenko LF
    Ter Arkh; 1986; 58(2):76-9. PubMed ID: 3704946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of suppressor function of human peripheral blood T cells by (+)cyanidanol-3: its application to chronic active liver diseases.
    Kakumu S; Murakami H; Kuriki J
    Clin Exp Immunol; 1983 May; 52(2):430-6. PubMed ID: 6222856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of silymarin and (+)-cyanidanol-3 on hexachlorobenzene(HCB)-induced porphyria in rats].
    Siegers CP
    Z Gastroenterol; 1982 Dec; 20(12):757-8. PubMed ID: 7164529
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro and in vivo demonstration of the cytoprotective effect of (+)-cyanidanol-3.
    Altorjay I; Dalmi L; Sári B
    Acta Physiol Hung; 1984; 64(3-4):471-4. PubMed ID: 6532130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of (+)-cyanidanol-3 on toxic fatty infiltration of liver parenchyma (author's transl)].
    Meiss R; Rassat J; Themann H
    Arzneimittelforschung; 1982; 32(2):139-40. PubMed ID: 6802144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial.
    Bar-Meir S; Halpern Z; Gutman M; Shpirer Z; Baratz M; Bass D
    Gut; 1985 Sep; 26(9):975-9. PubMed ID: 3896964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of acute viral hepatitis with (+)-cyanidanol-3.
    Blum AL; Berthet P; Doelle W; Goebell H; Kortüm K; Pelloni S; Peter P; Poulsen H; Strohmeyer G; Tygstrup N
    Lancet; 1977 Dec; 2(8049):1153-5. PubMed ID: 73062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Catergen in the treatment of chronic liver diseases].
    Semendiaeva ME; Eremeeva EP; Kodrian AA; Kamaeva NG
    Sov Med; 1986; (9):47-50. PubMed ID: 3541245
    [No Abstract]   [Full Text] [Related]  

  • 30. [Preliminary evaluation of catergen (Zyma) in the treatment of acute viral hepatitis (author's transl)].
    Sowa J; Odrobina S; Mossor-Ostrowska J
    Przegl Lek; 1980; 37(7):573-7. PubMed ID: 6997933
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of (+)-cyanidanol-3- on acute viral hepatitis. Preliminary results].
    Guadagnino V; De Mercato R; Piazza M
    Clin Ter; 1977 Dec; 83(5):463-8. PubMed ID: 608309
    [No Abstract]   [Full Text] [Related]  

  • 32. The development of cianidanol and 3-palmitoyl-(+)-catechin as drugs for the treatment of liver diseases.
    Perrissoud D
    Prog Clin Biol Res; 1986; 213():559-69. PubMed ID: 3520595
    [No Abstract]   [Full Text] [Related]  

  • 33. (+)-Cyanidanol-3 in the treatment of acute viral hepatitis: a randomized controlled trial.
    Schomerus H; Wiedmann KH; Dölle W; Peerenboom H; Strohmeyer G; Balzer K; Goebell H; Dürr HK; Bode C; Blum AL
    Hepatology; 1984; 4(2):331-5. PubMed ID: 6368355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The value of Catergen].
    Orv Hetil; 1983 Jun; 124(23):1411-2. PubMed ID: 6877819
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of cyanidanol-3 on lysosomal enzyme activity of serum and granulocytes in chronic liver disease and active hepatitis.
    Fehér J; Toncsev H; Sréter L; Cornides A; Kiss A
    Int J Tissue React; 1984; 6(1):75-80. PubMed ID: 6715121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of silymarin and (+)-cyanidanol-3 on the HCB-induced porphyria in rats (author's transl)].
    Thier W; Bolsen K; Goerz G
    Z Gastroenterol; 1982 Jan; 20(1):40-6. PubMed ID: 7064495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A double-blind clinical study of the effect of a new molecule (+)-cyanidanol-3 on the course of the clinical symptoms and biological parameters of viral hepatitis].
    Cachin M; Dupuy R; Boutelier D; Levy C
    Minerva Dietol Gastroenterol; 1977; 23(4):307-12. PubMed ID: 349422
    [No Abstract]   [Full Text] [Related]  

  • 38. [The treatment of acute viral hepatitis with (+)-cyanidanol-3].
    Pelloni S; Berthet P; Blum AL; Doelle W; Goebell H; Kortüm K; Peter P; Poulsen H; Strohmeyer G; Tygstrup N
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1859-61. PubMed ID: 337476
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of patients with disorders of the biotransformation function of the liver with (+)-cyanidanol-3].
    Jabłkowski M; Adamska-Dyniewska H; Dziekański S
    Pol Tyg Lek; 1987 Oct; 42(43):1355-8. PubMed ID: 3328178
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of (+)-cyanidanol-3 on receptor activity of lymphocytes and hepatocytes and on hepatocyte-lymphocyte conjugation in alcoholic liver disease.
    Sipos J; Gabor V; Toth Z; Ribiczey P
    Int J Tissue React; 1984; 6(2):145-54. PubMed ID: 6203861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.